BAILLIE GIFFORD & CO - 30 Sep 2024 SCHEDULE 13G/A Report for RECURSION PHARMACEUTICALS, INC. Common Stock (DNA)

Filing Manager: BAILLIE GIFFORD & CO
Reporting Manager: BAILLIE GIFFORD & CO
Security: RECURSION PHARMACEUTICALS, INC. Common Stock
Symbol: DNA
Shares outstanding: 274,346,413 shares
Disclosed Ownership: 25,239,870 shares
Ownership: 9.2%
Form type: SCHEDULE 13G/A
Filing time: 04 Nov 2024, 09:46:16 UTC
Date of event: 30 Sep 2024
Next filing: 12 Feb 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BAILLIE GIFFORD & CO	9.2%	25,239,870	25,162,631	0	Grant Meikle	Threshold & Transaction Reporting Manager